Mechanisms of heme utilization by Francisella tularensis

PLoS One. 2015 Mar 10;10(3):e0119143. doi: 10.1371/journal.pone.0119143. eCollection 2015.

Abstract

Francisella tularensis is a highly virulent facultative intracellular pathogen causing the severe disease tularemia in mammals. As for other bacteria, iron is essential for its growth but very few mechanisms for iron acquisition have been identified. Here, we analyzed if and how F. tularensis can utilize heme, a major source of iron in vivo. This is by no means obvious since the bacterium lacks components of traditional heme-uptake systems. We show that SCHU S4, the prototypic strain of subspecies tularensis, grew in vitro with heme as the sole iron source. By screening a SCHU S4 transposon insertion library, 16 genes were identified as important to efficiently utilize heme, two of which were required to avoid heme toxicity. None of the identified genes appeared to encode components of a potential heme-uptake apparatus. Analysis of SCHU S4 deletion mutants revealed that each of the components FeoB, the siderophore system, and FupA, contributed to the heme-dependent growth. In the case of the former two systems, iron acquisition was impaired, whereas the absence of FupA did not affect iron uptake but led to abnormally high binding of iron to macromolecules. Overall, the present study demonstrates that heme supports growth of F. tularensis and that the requirements for the utilization are highly complex and to some extent novel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ferrous Compounds / metabolism
  • Francisella tularensis / genetics
  • Francisella tularensis / growth & development
  • Francisella tularensis / metabolism*
  • Gene Expression Regulation, Bacterial
  • Genes, Bacterial
  • Heme / metabolism*
  • Metabolic Networks and Pathways / genetics*

Substances

  • Ferrous Compounds
  • ferrous sulfate
  • Heme

Grants and funding

The work was funded by the Swedish Medical Research Council (www.vr.se K2013-56X-22356-01-3), the Kempe foundation and the Medical Faculty, Umeå University, Umeå, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.